Spots Global Cancer Trial Database for localized gallbladder cancer

Every month we try and update this database with for localized gallbladder cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer	NCT00274885	Cancer	oxaliplatin management of t...	18 Years -	National Cancer Institute (NCI)
BMS-247550 in Treating Patients With Liver or Gallbladder Cancer	NCT00023946	Adult Primary C... Adult Primary H... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Localized Extra... Localized Gallb... Localized Resec... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	ixabepilone laboratory biom...	18 Years -	National Cancer Institute (NCI)
DX-8951f in Treating Patients With Biliary Cancer	NCT00005938	Extrahepatic Bi... Gallbladder Can... Liver Cancer	exatecan mesyla...	16 Years -	Daiichi Sankyo
S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct	NCT00789958	Extrahepatic Bi... Gallbladder Can...	capecitabine gemcitabine hyd... 3-dimensional c... intensity-modul...	18 Years - 120 Years	SWOG Cancer Research Network
Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer	NCT00544193	Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine...	gemcitabine hyd... polymerase chai... immunohistochem... conventional su... intraoperative ... radiation thera...	18 Years - 70 Years	City of Hope Medical Center
Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract	NCT00012246	Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine...	carcinoembryoni... incomplete Freu... sargramostim	18 Years -	The University of Texas Medical Branch, Galveston
Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer	NCT00363584	Extrahepatic Bi... Gallbladder Can... Liver Cancer	capecitabine clinical observ... adjuvant therap...	18 Years -	National Cancer Institute (NCI)
Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder	NCT00489515	Colorectal Canc... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine...		18 Years - 120 Years	Wake Forest University Health Sciences
Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract	NCT00012246	Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine...	carcinoembryoni... incomplete Freu... sargramostim	18 Years -	The University of Texas Medical Branch, Galveston
BMS-247550 in Treating Patients With Liver or Gallbladder Cancer	NCT00023946	Adult Primary C... Adult Primary H... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Localized Extra... Localized Gallb... Localized Resec... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	ixabepilone laboratory biom...	18 Years -	National Cancer Institute (NCI)
Everolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refractory to Standard Therapy	NCT00949949	Cholangiocarcin... Localized Gallb... Unresectable Ga... Unspecified Adu...	everolimus gemcitabine hyd... cisplatin	18 Years -	Mayo Clinic
EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer	NCT00087191	Advanced Adult ... Carcinoma of th... Fallopian Tube ... Gastrointestina... Localized Extra... Localized Gallb... Localized Gastr... Localized Resec... Localized Unres... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Primary Periton... Recurrent Adult... Recurrent Adult... Recurrent Colon... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Small... Recurrent Uteri... Regional Gastro... Small Intestine... Small Intestine... Small Intestine... Stage 0 Non-sma... Stage I Adult S... Stage I Colon C... Stage I Gastric... Stage I Non-sma... Stage I Ovarian... Stage I Ovarian... Stage I Pancrea... Stage I Rectal ... Stage I Uterine... Stage II Adult ... Stage II Colon ... Stage II Gastri... Stage II Non-sm... Stage II Ovaria... Stage II Ovaria... Stage II Pancre... Stage II Rectal... Stage II Uterin... Stage III Adult... Stage III Colon... Stage III Gastr... Stage III Ovari... Stage III Ovari... Stage III Pancr... Stage III Recta... Stage III Uteri... Stage IIIA Non-... Stage IIIB Non-... Stage IV Adult ... Stage IV Colon ... Stage IV Gastri... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Rectal... Stage IV Uterin... Unresectable Ex... Unresectable Ga...	EF5 motexafin lutet... pharmacological...	18 Years -	National Cancer Institute (NCI)
Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer	NCT00363584	Extrahepatic Bi... Gallbladder Can... Liver Cancer	capecitabine clinical observ... adjuvant therap...	18 Years -	National Cancer Institute (NCI)
Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer	NCT00003296	Extrahepatic Bi... Gallbladder Can... Liver Cancer	filgrastim pegylated lipos...	18 Years -	National Cancer Institute (NCI)
Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen	NCT00016380	Cancer	dexamethasone ondansetron quality-of-life...	16 Years - 120 Years	Canadian Cancer Trials Group
Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery	NCT01313377	Extrahepatic Bi... Gallbladder Can... Liver Cancer	gemcitabine hyd... oxaliplatin clinical observ... adjuvant therap... quality-of-life...	18 Years - 120 Years	UNICANCER
DX-8951f in Treating Patients With Biliary Cancer	NCT00005938	Extrahepatic Bi... Gallbladder Can... Liver Cancer	exatecan mesyla...	16 Years -	Daiichi Sankyo
DX-8951f in Treating Patients With Biliary Cancer	NCT00005938	Extrahepatic Bi... Gallbladder Can... Liver Cancer	exatecan mesyla...	16 Years -	Daiichi Sankyo
S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct	NCT00789958	Extrahepatic Bi... Gallbladder Can...	capecitabine gemcitabine hyd... 3-dimensional c... intensity-modul...	18 Years - 120 Years	SWOG Cancer Research Network
Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer	NCT00003296	Extrahepatic Bi... Gallbladder Can... Liver Cancer	filgrastim pegylated lipos...	18 Years -	National Cancer Institute (NCI)
Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer	NCT00544193	Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine...	gemcitabine hyd... polymerase chai... immunohistochem... conventional su... intraoperative ... radiation thera...	18 Years - 70 Years	City of Hope Medical Center
Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen	NCT00016380	Cancer	dexamethasone ondansetron quality-of-life...	16 Years - 120 Years	Canadian Cancer Trials Group
Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery	NCT01313377	Extrahepatic Bi... Gallbladder Can... Liver Cancer	gemcitabine hyd... oxaliplatin clinical observ... adjuvant therap... quality-of-life...	18 Years - 120 Years	UNICANCER
Everolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refractory to Standard Therapy	NCT00949949	Cholangiocarcin... Localized Gallb... Unresectable Ga... Unspecified Adu...	everolimus gemcitabine hyd... cisplatin	18 Years -	Mayo Clinic
BMS-247550 in Treating Patients With Liver or Gallbladder Cancer	NCT00023946	Adult Primary C... Adult Primary H... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Localized Extra... Localized Gallb... Localized Resec... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	ixabepilone laboratory biom...	18 Years -	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: